The George Institute for Global Health Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Private

  • Employees
  • 700

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $22M

  • Investors
  • 4

The George Institute for Global Health General Information

Description

Operator of a for-profit global healthcare firm intended to deliver affordable, scalable treatments and technologies. The company focuses on the late-stage clinical development of medicines and treatments by combining established drugs in innovative fixed-dose formulations for patients with cardiometabolic diseases, such as heart disease, hypertension, and diabetes, enabling the healthcare industry to provide treatments that are more efficacious, safer, and affordable than current alternatives.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Level 8, Health Translation Hub
  • 55 Botany Street, Randwick
  • Sydney, New South Wales 2031
  • Australia
+61 (02)
Primary Industry
Clinics/Outpatient Services
Other Industries
Other Healthcare Services
Corporate Office
  • Level 8, Health Translation Hub
  • 55 Botany Street, Randwick
  • Sydney, New South Wales 2031
  • Australia
+61 (02)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

The George Institute for Global Health Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 10-Mar-2020 $22M Completed Generating Revenue
1. Grant 01-Jan-2013 Completed Startup
To view The George Institute for Global Health’s complete valuation and funding history, request access »

The George Institute for Global Health Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a for-profit global healthcare firm intended to deliver affordable, scalable treatments and technologies. Th
Clinics/Outpatient Services
Sydney, Australia
700 As of 2026

Sao Paulo, Brazil

Ahmedabad, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

The George Institute for Global Health Competitors (3)

One of The George Institute for Global Health’s 3 competitors is Glenmark Farmacêutica, a Corporation company based in Sao Paulo, Brazil.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Glenmark Farmacêutica Corporation Sao Paulo, Brazil
Intas Pharmaceuticals Private Equity-Backed Ahmedabad, India
Ability Pharma Private Equity-Backed Cerdanyola, Spain
You’re viewing 3 of 3 competitors. Get the full list »

The George Institute for Global Health Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

The George Institute for Global Health Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Brandon Capital Venture Capital Minority
Bupa HI Corporation Minority
Federation Asset Management PE/Buyout Minority
National Health and Medical Research Council Government
To view The George Institute for Global Health’s complete investors history, request access »

The George Institute for Global Health Investments (9)

The George Institute for Global Health’s most recent deal was a Accelerator/Incubator with Roam Technologies for . The deal was made on 20-Oct-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Roam Technologies 20-Oct-2025 Accelerator/Incubator Other Devices and Supplies
GonGlobal 10-Oct-2024 Accelerator/Incubator Biotechnology
Gheorg 26-Oct-2023 Accelerator/Incubator Clinics/Outpatient Services
NeoGenix Biosciences 09-Jan-2023 Accelerator/Incubator Other Healthcare Technology Systems
Resonait 22-Nov-2022 Accelerator/Incubator Therapeutic Devices
You’re viewing 5 of 9 investments. Get the full list »

The George Institute for Global Health FAQs

  • When was The George Institute for Global Health founded?

    The George Institute for Global Health was founded in 1999.

  • Where is The George Institute for Global Health headquartered?

    The George Institute for Global Health is headquartered in Sydney, Australia.

  • What is the size of The George Institute for Global Health?

    The George Institute for Global Health has 700 total employees.

  • What industry is The George Institute for Global Health in?

    The George Institute for Global Health’s primary industry is Clinics/Outpatient Services.

  • Is The George Institute for Global Health a private or public company?

    The George Institute for Global Health is a Private company.

  • What is The George Institute for Global Health’s current revenue?

    The current revenue for The George Institute for Global Health is .

  • How much funding has The George Institute for Global Health raised over time?

    The George Institute for Global Health has raised $22M.

  • Who are The George Institute for Global Health’s investors?

    Brandon Capital, Bupa HI, Federation Asset Management, and National Health and Medical Research Council have invested in The George Institute for Global Health.

  • Who are The George Institute for Global Health’s competitors?

    Glenmark Farmacêutica, Intas Pharmaceuticals, and Ability Pharma are competitors of The George Institute for Global Health.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process